HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r)+2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r plus raltegravir as second-line antiretroviral therapy

Martin, Allison, Moore, Cecilia L., Mallon, Patrick W. G., Hoy, Jennifer F., Emery, Sean, Belloso, Waldo H., Phanuphak, Praphan, Ferret, Samuel, Cooper, David A. and Boyd, Mark A. (2013) HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r)+2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r plus raltegravir as second-line antiretroviral therapy. PLoS One, 8 10: . doi:10.1371/journal.pone.0077138


Author Martin, Allison
Moore, Cecilia L.
Mallon, Patrick W. G.
Hoy, Jennifer F.
Emery, Sean
Belloso, Waldo H.
Phanuphak, Praphan
Ferret, Samuel
Cooper, David A.
Boyd, Mark A.
Title HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r)+2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r plus raltegravir as second-line antiretroviral therapy
Journal name PLoS One   Check publisher's open access policy
ISSN 1932-6203
Publication date 2013-10-30
Year available 2013
Sub-type Article (original research)
DOI 10.1371/journal.pone.0077138
Open Access Status DOI
Volume 8
Issue 10
Total pages 9
Place of publication San Francisco, CA, United States
Publisher Public Library of Science
Language eng
Keyword Multidisciplinary Sciences
Science & Technology - Other Topics
MULTIDISCIPLINARY SCIENCES
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 9 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 18 Mar 2017, 01:00:47 EST by Web Cron on behalf of Learning and Research Services (UQ Library)